Search Within

Martee L Hensley

Formats
  1. Journal Article (174)
  2. Meeting Abstract (106)
  3. Book Section (7)
  4. Correspondence (1)
  5. Editorial (1)
  6. Guidelines (1)
Groups
  1. Department of Medicine (290)
  2. GDMT, Medicine (290)
  3. Gynecologic Medicine Service (290)
  4. Gynecology Disease Management Team (290)
  5. Solid Tumor Oncology Division (290)
  6. Surgery (129)

More Groups

People
  1. Carol Aghajanian (94)
  2. Paul Sabbatini (81)
  3. Robert Soslow (63)
  4. David Spriggs (55)
  5. Mario Leitao (53)
  6. Richard Barakat (53)

More People

Years
  1. 2025 (3)
  2. 2024 (9)
  3. 2023 (11)
  4. 2022 (16)
  5. 2021 (6)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (80)
  2. Gynecologic Oncology (73)
  3. International Journal of Gynecological Cancer (22)
  4. Modern Pathology (18)
  5. Clinical Cancer Research (15)
  6. Laboratory Investigation (11)

More Publications

Publishers
  1. American Society of Clinical Oncology (83)
  2. Elsevier Inc. (81)
  3. Lippincott Williams & Wilkins (33)
  4. Nature Research (18)
  5. American Association for Cancer Research (17)
  6. Nature Publishing Group (13)

More Publishers

Results (290)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial
    Journal Article

    Hensley, M. L.; Patel, S. R.; von Mehren, M.; Ganjoo, K.; Jones, R. L.; Staddon, A.; Rushing, D.; Milhem, M.; Monk, B.; Wang, G.; more...
    Gynecologic Oncology (2017)

    Fulltext@MSK | Save
  • YWHAE-rearranged high-grade endometrial stromal sarcoma: Two-center case series and response to chemotherapy
    Journal Article

    Hemming, M. L.; Wagner, A. J.; Nucci, M. R.; Chiang, S.; Wang, L.; Hensley, M. L.; George, S.
    Gynecologic Oncology (2017)

    Fulltext@MSK | Save
  • BCOR is a robust diagnostic immunohistochemical marker of YWHAE-rearranged high-grade endometrial stromal sarcoma
    Meeting Abstract

    Chiang, S.; Hensley, M.; Antonescu, C. R.; Oliva, E.; Soslow, R.
    Modern Pathology (2017)

    Fulltext@MSK | Save
  • BCOR is a robust diagnostic immunohistochemical marker of YWHAE-rearranged high-grade endometrial stromal sarcoma
    Meeting Abstract

    Chiang, S.; Hensley, M.; Antonescu, C. R.; Oliva, E.; Soslow, R.
    Laboratory Investigation (2017)

    Fulltext@MSK | Save
  • Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study
    Journal Article

    Mai, P. L.; Piedmonte, M.; Han, P. K.; Moser, R. P.; Walker, J. L.; Rodriguez, G.; Boggess, J.; Rutherford, T. J.; Zivanovic, O.; Cohn, D. E.; more...
    Gynecologic Oncology (2017)

    Fulltext@MSK | Save
  • Novel high-grade endometrial stromal sarcoma: A morphologic mimicker of myxoid leiomyosarcoma
    Journal Article

    Hoang, L. N.; Aneja, A.; Conlon, N.; Delair, D. F.; Middha, S.; Benayed, R.; Hensley, M. L.; Park, K. J.; Hollmann, T. J.; Hameed, M. R.; more...
    American Journal of Surgical Pathology (2017)

    Fulltext@MSK | Save
  • A phase 2 study of alisertib (MLN8237) in recurrent or persistent uterine leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group study 0231D
    Journal Article

    Hyman, D. M.; Sill, M. W.; Lankes, H. A.; Piekarz, R.; Shahin, M. S.; Ridgway, M. R.; Backes, F.; Tenney, M. E.; Mathews, C. A.; Hoffman, J. S.; more...
    Gynecologic Oncology (2017)

    Fulltext@MSK | Save
  • Patient-reported outcomes from randomized, phase-3 study of trabectedin (T) vs. dacarbazine (D) in advanced Ieiomyosarcoma (LMS) or liposarcoma (LPS)
    Meeting Abstract

    Demetri, G. D.; von Mehren, M.; Jones, R. L.; Hensley, M. L.; Schuetze, S.; Elias, A. D.; Pierson, R. F.; Knoblauch, R. E.; Park, Y. C.; Wang, G. C.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high grade undifferentiated uterine sarcoma (HGUS) after stabilization or response to doxorubicin +/- ifosfamide following surgery or in metastatic first line treatment
    Meeting Abstract

    Ray-Coquard, I. L.; Tos, A. P. D.; Coens, C.; Huizing, M.; Herraez, A. C.; Westermann, A. M.; Bompas, E.; Earl, H.; Hensley, M. L.; Negrouk, A.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Efficacy and safety of trabectedin or dacarbazine for metastatic liposarcoma or leiomyosarcoma after failure of conventional chemotherapy: Results of a phase III randomized multicenter clinical trial
    Journal Article

    Demetri, G. D.; von Mehren, M.; Jones, R. L.; Hensley, M. L.; Schuetze, S. M.; Staddon, A.; Milhem, M.; Elias, A.; Ganjoo, K.; Tawbi, H.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save